David Yeghikyan

Title: David Yeghikyan: Innovator in KAT6A Inhibition

Introduction

David Yeghikyan is a notable inventor based in Fremont, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work focuses on creating innovative solutions for medical challenges.

Latest Patents

David Yeghikyan holds a patent for acylsulfonamide KAT6A inhibitors. The present disclosure describes acylsulfonamide compounds of Formula (J), along with their pharmaceutically acceptable salts, compositions, methods, and uses. These compounds are believed to be therapeutically useful as KAT6A inhibitors, particularly in the treatment and prevention of diseases and disorders mediated by KAT6A in a subject. He has 1 patent to his name.

Career Highlights

Throughout his career, David has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Olema Pharmaceuticals, Inc. and Aurigene Oncology Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

David has collaborated with various professionals in his field, including his coworker David C Myles. These collaborations have enhanced his research and development efforts, leading to advancements in therapeutic solutions.

Conclusion

David Yeghikyan is a dedicated inventor whose work in KAT6A inhibition showcases his commitment to advancing medical science. His innovative approach and contributions to the pharmaceutical industry highlight the importance of research and development in addressing complex health issues.